tradingkey.logo

ProAssurance shareholders approve acquisition by The Doctors Company

ReutersJun 25, 2025 12:43 PM

By Mia MacGregor

- (The Insurer) - ProAssurance Corporation stockholders have overwhelmingly voted to approve its proposed acquisition by The Doctors Company.

More than 99% of shares, including abstentions, were in favour of the acquisition agreement, according to the company.

In March 2025, The Doctors Company agreed to acquire ProAssurancefor $25 per share in cash, valuing the New York-listed medical liability insurer at $1.3 billion.

The transaction is still subject to regulatory approvals and other customary closing conditions. The deal is expected to close in the first half of 2026.

Upon completion, ProAssurance’s common stock will no longer be listed on the New York Stock Exchange, and the company will become a wholly owned subsidiary of The Doctors Company.

“Bringing the strengths and capabilities of ProAssurance and The Doctors Company together will allow our teams to continue to serve today’s healthcare providers with the necessary scale and breadth of capabilities,” said Ned Rand, ProAssurance’s president and CEO.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI